How can you ensure your product achieves optimal market access during a global economic recession?
Thursday 9th July at 2pm BST / 9am EST
Choosing a price for a new product, and then justifying that price to payers, is a challenge for all pharmaceutical and biotechnology companies. This challenge becomes even more difficult if you are launching a product during a global economic recession. A panel of experts in pricing, chaired by our Senior Executive Advisor, Raf De Wilde, will discuss how best to navigate these pricing challenges and make sure you achieve the optimal price for your product.
Sign up for this webinar now here.
The panel for this webinar consists of:
- Anusha Patel, High Cost Medicines and Regional Homecare Lead Pharmacist for the East Midlands; Advisor to NICE and NHS England
- Bertrand Tardivel Former Head of Global Pricing at Takeda; founder of Freh
- Jaime Espin Former Member of the WHO Guideline Panel on Country Pharmaceutical Pricing Policies, and pricing advisor to the European Commission
